1-6 of 6
Qinglong Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparative Analysis of Immune Effector Cell-Associated Hematotoxicity (ICAHT) and Infection Incidence Following CD19-Targeted CAR-T Therapy Versus CD7-Targeted CAR-T Therapy

Xian Zhang, Qinglong Wang, Ying Liu, Junfang Yang, Jingjing Li, Hongxing Liu, Jianqiang Li, Peihua Lu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6883.
https://doi.org/10.1182/blood-2023-185361
Published: 2023
Journal Articles

Naturally selected CD7 CAR-T therapy without genetic manipulations for T-ALL/LBL: first-in-human phase 1 clinical trial

Clinical Trials & Observations
Peihua Lu, Ying Liu, Junfang Yang, Xian Zhang, Xiao Yang, Hui Wang, Lin Wang, Qinglong Wang, David Jin, Jianqiang Li, Xiaojun Huang
Journal: Blood
Blood (2022) 140 (4): 321–334.
https://doi.org/10.1182/blood.2021014498
Published: 2022
Includes: Supplemental data
Journal Articles

Naturally Selected Anti-CD7 CAR-T Cells without Additional Genetic Manipulations As a Potentially Superior Therapy for T-Cell Malignancies

Ying Liu, Weijing Li, Lin Wang, Min Ba, Qinglong Wang, Peihua Lu, Lihong Liu, Jianqiang Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 1696.
https://doi.org/10.1182/blood-2021-149384
Published: 2021
Journal Articles

A Novel and Successful Patient or Donor-Derived CD7-Targeted CAR T-Cell Therapy for Relapsed or Refractory T-Cell Lymphoblastic Lymphoma (R/R T-LBL)

Junfang Yang, Xiao Yang, Ying Liu, Qinglong Wang, Hui Wang, Jianqiang Li, Peihua Lu
Journal: Blood
Blood (2021) 138 (Supplement 1): 652.
https://doi.org/10.1182/blood-2021-147754
Published: 2021
Journal Articles

Surface Density of CAR Molecules May Modulate the Kinetics of CAR-T Cells In Vivo

Jianqiang Li, PhD, Jin-Yuan Ho, PhD, Lin Wang, Xing Niu, Min Ba, Qinglong Wang, Junfang Yang, MD, Xian Zhang, MD, Dandan Chen, Peihua Lu
Journal: Blood
Blood (2019) 134 (Supplement_1): 54.
https://doi.org/10.1182/blood-2019-125467
Published: 2019
Journal Articles

A Feasibility and Safety Study of CD19 and CD22 Chimeric Antigen Receptors-Modified T Cell Cocktail for Therapy of B Cell Acute Lymphoblastic Leukemia

Junfang Yang, MD, Jianqiang Li, Xian Zhang, PhD, Fanyong LV, Xiaoling Guo, Qinglong Wang, Lin Wang, Dandan Chen, Xiaosu Zhou, Jinhai Ren, MD, Peihua Lu
Journal: Blood
Blood (2018) 132 (Supplement 1): 277.
https://doi.org/10.1182/blood-2018-99-114415
Published: 2018